Intangible Assets

HEPA’s negative TTM ROIC/ROCE indicates it is not converting capital into excess returns, which is inconsistent with durable intangible pricing power versus peers.

The provided metrics show no evidence of sustained margin or growth premium, so any brand or proprietary know-how is not translating into a measurable moat relative to peers.

With no disclosed long-run profitability history in the supplied data, there is no support for durable customer willingness to pay more than alternatives.

Compared with stronger peers that typically show positive and persistent returns on capital, HEPA’s current economics suggest limited intangible asset strength.

Switching Costs

The supplied data do not show retention, contract stickiness, or embedded workflow dependence, so customers appear able to switch without material economic friction.

Negative returns on capital imply HEPA is not capturing recurring value from installed relationships, which weakens the case for switching costs versus peers.

No evidence of recurring revenue durability or renewal advantage is provided, so switching costs cannot be inferred as a structural support.

Relative to peers with software-like lock-in or regulated customer dependence, HEPA shows no visible switching-cost moat in the available metrics.

Network Effects

The provided metrics contain no sign of user-to-user, data, or ecosystem feedback loops that would make the business more valuable as it scales.

Negative ROIC and zero asset turnover do not indicate a self-reinforcing platform dynamic, which argues against network effects versus peers.

No evidence of marketplace liquidity, multi-sided participation, or data accumulation advantages is present in the supplied information.

Compared with peer businesses that benefit from compounding adoption or ecosystem gravity, HEPA shows no observable network-effect advantage.

Cost Advantage

Negative TTM ROIC/ROCE suggests HEPA is not operating with a cost structure that produces durable excess returns versus peers.

The absence of positive margin data prevents evidence of procurement, manufacturing, or scale efficiencies that would lower unit costs sustainably.

Zero asset turnover in the supplied metrics does not support a claim of superior operating efficiency relative to competitors.

Compared with peers that consistently convert assets into higher returns, HEPA’s current economics do not indicate a cost advantage moat.

Efficient Scale

The available data do not show a concentrated market structure or capacity discipline that would allow HEPA to benefit from efficient scale versus peers.

Negative returns on capital imply the business is not earning scarcity rents from a protected niche or limited-demand market.

No evidence of regulatory barriers, local monopoly economics, or natural capacity constraints is provided in the supplied metrics.

Relative to peers with durable efficient-scale advantages, HEPA shows no measurable sign of structural scale protection.

Overall Score

HEPA’s moat appears weak versus peers because the supplied metrics show negative returns on capital and no evidence of switching costs, network effects, cost advantage, or efficient scale; on the available data, the business does not demonstrate durable pricing power or retention over a 5–10 year horizon.